Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Wellbutrin XL Ad Notes Suicidality Risk, Does Not Reflect “Black Box”

Executive Summary

A new GlaxoSmithKline television ad for the antidepressant Wellbutrin XL includes information about suicidality and mood changes

You may also be interested in...



FDA Takes Relaxed Stance On DTC Ads For Products With “Black Box”

FDA is not requiring the inclusion of the full text of a "black box" warning in new direct-to-consumer advertisements for antidepressants

FDA Takes Relaxed Stance On DTC Ads For Products With “Black Box”

FDA is not requiring the inclusion of the full text of a "black box" warning in new direct-to-consumer advertisements for antidepressants

FDA Awaits More Effexor Data Following U.K. Regulatory Changes

FDA is awaiting further data on Wyeth's Effexor following U.K. regulatory changes for the antidepressant

Related Content

Topics

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel